- Case report
- Open Access
- Open Peer Review
Penile metastasis from primary transitional cell carcinoma of the renal pelvis: first manifestation of systemic spread
© Pomara et al; licensee BioMed Central Ltd. 2004
- Received: 29 June 2004
- Accepted: 03 December 2004
- Published: 03 December 2004
Almost one-third of all penile metastases are detected at the same time as a primary tumor, whereas the remaining two-thirds are detected a mean of 18 months after the discovery of the primary tumor. Cutaneous metastasis of transitional cell carcinoma (TCC) is extremely rare and generally accepted as the late manifestation of a systemic spread.
We report the first case of simultaneous penile and lung metastases from a primary TCC of the renal pelvis in a 76-year-old man, that occurred 8 years after a left nephroureterectomy.
This case report underscores the importance of physical examinations of the skin of patients who undergo surgical procedures for TCC from bladder as well as from the upper urinary tract, including those seemingly without metastatic disease, because of the possibility of skin and penile metastatic spread.
- Renal Pelvis
- Transitional Cell Carcinoma
- Systemic Spread
- Superficial Bladder Cancer
Approximately 300 cases of penile metastases are reported worldwide . Seventy percent of these metastases have their origin in the genitourinary tract, and the primary tumor is most frequently located in the bladder . We present the first case of penile metastasis from primary transitional cell carcinoma (TCC) of the renal pelvis, and discuss the striking feature of discovering lung metastasis almost simultaneously.
The patient began combination chemotherapy (gemcitabine at 1250 mg/m2 on days 1, 8, and 15, and then every 28 days for six courses) and external beam radiotherapy to the mass, which promptly relieved the penile pain. At an 8-month follow-up the patient was still alive with no remarkable changes to the pulmonary and lymph node metastases, or the penile swelling.
Cutaneous metastases from primary TCC of the urinary system are extremely rare and are generally accepted as late manifestations of systemic spread . Spector et al. (1987) suggested that skin metastases in TCC were the result of increased longevity in successfully treated patients . Various mechanisms by which lesions may metastasize to the penis have been reported. Recently Bordeau and Lynch and Berger et al. reported three cases of penile metastases from TCC of the bladder in which they assumed that metastatic spread from primary bladder cancer to the penis occurred mainly via the retrograde venous route [2, 4]. There are also a few reports of TCC seeding outside the urinary tract after iatrogenic procedures (i.e., partial cystectomy, suprapubic cystostomy, pyelotomy, and laparoscopy) as the cause of cutaneous metastasis [1, 5, 6]. Between 5% and 20% of patients with superficial bladder cancer have vascular or lymphatic spread , and the reported rate of skin metastasis from TCC of the bladder is between 0.2% and 2% . The rate of skin metastasis from TCC of the renal pelvis is currently unknown, and to the best of our knowledge ours is the first reported case of penile metastasis from TCC of the upper urinary tract.
Almost one-third of all penile metastases are generally detected at the same time as a primary tumor, whereas the remaining two-thirds are detected a mean of 18 months after the discovery of the primary tumor . Because the disease-free survival of this patient was 8 years following the diagnosis of the primary tumor, this case report represents a description of the biology of an unusual tumor. Moreover, the penile metastasis in this case was not the late manifestation of systemic spread, as is usually reported in the literature ; in fact, the patient was accurately evaluated with a standard follow-up scheme. Therefore, it is plausible that the lung metastasis appears almost simultaneously with the penile metastasis.
The optimal treatment of penile metastasis requires a multidisciplinary approach that is correlated with the disease extent. The average survival in patients with penile metastasis is 3.9 months from diagnosis and, with extensive surgery and chemotherapy, a survival of 9.2 months has been reported .
This patient was not eligible for platinum-based regimens due to impaired renal function (prior nephrectomy) and advanced age. As a result, he was treated with gemcitabine as a single agent. This treatment has demonstrated objective response rates of 25–29% with minimal toxicity as compared to standard regimens [9–11].
In conclusion, this case report suggests that particular attention should be paid to physical examination of the skin of patients who undergo surgical procedures for TCC from bladder as well as from the upper urinary tract, including those seemingly without metastatic disease, because of the possibility of skin and penile metastatic spread.
The patient gave his approval for publication.
- Akman Y, Cam K, Kavak A, Alper M: Extensive cutaneous metastasis of transitional cell carcinoma of the bladder. Int J Urol. 2003, 10: 103-104. 10.1046/j.1442-2042.2003.00571.x.View ArticlePubMedGoogle Scholar
- Bordeau KJ, Lynch DF: Transitional cell carcinoma of the bladder metastatic to the penis. Urology. 2004, 63 (5): 981-983. 10.1016/j.urology.2003.12.033.View ArticlePubMedGoogle Scholar
- Spector JI, Zimbler H, De Leo M, Ross JS: Skin metastasis from transitional cell carcinoma. Urology. 1987, 29: 215-217. 10.1016/0090-4295(87)90159-2.View ArticlePubMedGoogle Scholar
- Berger AP, Rogatsch H, Hoeltl L, Steiner H, Bartsch G, Hobisch A: Late penile metastasis from primary bladder carcinoma. Urology. 2003, 62 (1): 145-10.1016/S0090-4295(03)00239-5.View ArticlePubMedGoogle Scholar
- Miyamoto T, Ikehara A, Araki M, Akaeda T, Mihara M: Cutaneous metastatic carcinoma of the penis:suspected metastasis implantation from a bladder tumor. J Urol. 2000, 163: 1519-10.1097/00005392-200005000-00030.View ArticlePubMedGoogle Scholar
- Andersen JR, Steven K: Implantation metastasis after laparoscopic biopsy of bladder cancer. J Urol. 1995, 153: 1047-10.1097/00005392-199503001-00038.View ArticlePubMedGoogle Scholar
- Zirwas MJ, Hunt S, Logan TF, Abernethy JL, Seraly MP: A painful cutaneous nodule as the presentation of metastatic transitional cell carcinoma of the renal pelvis. J Am Acad Dermatol. 2000, 42: 867-868. 10.1016/S0190-9622(00)90256-1.View ArticlePubMedGoogle Scholar
- Maier U, Grimm M: Transitional cell carcinoma of the bladder with solitary metastasis to the penis 4 years after successful heart transplantation. Transplantation. 1994, 58: 861-863.View ArticlePubMedGoogle Scholar
- Stadler WM, Kuzel T, Roth B, Raghavan D, Dorr FA: Phase II studyof single-agent gemcitabine in previously untreted patients with metastatic urothelial cancer. J Clin Oncol. 1997, 15: 3394-3399.PubMedGoogle Scholar
- Lorusso V, Pollera CF, Antimi M, Luporini G, Gridelli C, Frassineti GL, Oliva C, Pacini M, De Lena M: A phaseII study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Eur J Cancer. 1998, 34: 1208-1212. 10.1016/S0959-8049(98)00030-6.View ArticlePubMedGoogle Scholar
- Moore MJ, Tannock IF, Ernest DS, Huan S, Murray N: Gemcitabine a promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol. 1997, 15: 3441-3445.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://0-www.biomedcentral.com.brum.beds.ac.uk/1471-2407/4/90/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.